8-K: Current report
Published on October 24, 2008
|
UNITED
STATES
|
||||
|
SECURITIES
AND EXCHANGE COMMISSION
|
||||
|
Washington,
D.C. 20549
|
||||
|
|
||||
|
FORM
8-K
|
||||
|
|
||||
|
CURRENT
REPORT
|
||||
|
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
||||
|
|
||||
|
|
||||
|
Date
of report (Date of earliest event reported): October 24,
2008
|
||||
|
|
||||
|
IDEXX
LABORATORIES, INC.
|
||||
|
(Exact
name of registrant as specified in its charter)
|
||||
|
|
||||
|
Delaware
|
000-19271
|
01-0393723
|
||
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
||
|
of
incorporation)
|
|
|
||
|
|
||||
|
|
||||
|
One
IDEXX Drive, Westbrook, Maine
|
04092
|
|||
|
(Address
of principal executive offices)
|
(ZIP
Code)
|
|||
|
|
||||
|
207.556.0300
|
||||
|
(Registrant's
telephone number, including area code)
|
||||
|
|
||||
|
Not
Applicable
|
||||
|
(Former
name or former address, if changed since last
report)
|
||||
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions (see General Instruction A.2. to Form
8-K):
|
||||
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
|||
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|||
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|||
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
|||
|
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On
October 24, 2008, IDEXX Laboratories, Inc. (the “Company”) announced its
financial results for the quarter ended September 30, 2008. The full text of
the
press release issued in connection with the announcement is furnished as Exhibit
99.1 to this Current Report on Form 8-K.
In
accordance with general instructions to Form 8-K, the information in this Form
8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02
and
shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference
in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
| (d) |
Exhibits
|
The
following exhibit relating to Item 2.02 shall be deemed to be furnished, and
not
filed.
|
99.1
|
Press
Release entitled “IDEXX Laboratories Announces Third Quarter Results,”
issued by the company on October 24,
2008.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
IDEXX
LABORATORIES, INC.
|
||
|
Date:
October 24, 2008
|
By:
|
/s/
Merilee Raines
|
|
Merilee
Raines
|
||
|
Corporate
Vice President and
Chief
Financial Officer
|
||
3
EXHIBIT
INDEX
| Exhibit No. |
Description of
Exhibit
|
| 99.1 |
Press
Release entitled “IDEXX Laboratories Announces Third Quarter Results,”
issued by the company on October 24, 2008.
|
4